REPORT ID 6263

EMEA (Europe, Middle East and Africa) Penicillin/Streptomycin Market Report 2017

Publish Date
25-Dec-17
Pages
110
Format
Electronic (PDF)

In this report, the EMEA Penicillin/Streptomycin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Penicillin/Streptomycin for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Penicillin/Streptomycin market competition by top manufacturers/players, with Penicillin/Streptomycin sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Johnson & Johnson
    Pfizer
    Bayer HealthCare
    Abbot Laboratories
    Roche Pharmaceuticals
    Sanofi Aventis
    Takeda Pharmaceutical Company
    Toyama Chemical
    Merck & Co.
    MiddleBrook Pharmaceuticals
    Novartis
    Biogen IDEC
    Bristol Myers Squibb
    Celgine Corporation
    Eli Lilly and Co
    Gilead Sciences
    GlaxoSmithKline
    Amgen
    Astellas Pharma
    Astra Zeneca

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Penicillin
    Streptomycin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Penicillin/Streptomycin Market Report 2017
1 Penicillin/Streptomycin Overview
    1.1 Product Overview and Scope of Penicillin/Streptomycin
    1.2 Classification of Penicillin/Streptomycin
        1.2.1 EMEA Penicillin/Streptomycin Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Penicillin/Streptomycin Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Penicillin
        1.2.4 Streptomycin
    1.3 EMEA Penicillin/Streptomycin Market by Application/End Users
        1.3.1 EMEA Penicillin/Streptomycin Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 EMEA Penicillin/Streptomycin Market by Region
        1.4.1 EMEA Penicillin/Streptomycin Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Penicillin/Streptomycin (2012-2022)
        1.5.1 EMEA Penicillin/Streptomycin Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Penicillin/Streptomycin Revenue and Growth Rate (2012-2022)

2 EMEA Penicillin/Streptomycin Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Penicillin/Streptomycin Market Competition by Players/Manufacturers
        2.1.1 EMEA Penicillin/Streptomycin Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Penicillin/Streptomycin Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Penicillin/Streptomycin Sale Price by Players (2012-2017)
    2.2 EMEA Penicillin/Streptomycin (Volume and Value) by Type/Product Category
        2.2.1 EMEA Penicillin/Streptomycin Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Penicillin/Streptomycin Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Penicillin/Streptomycin Sale Price by Type (2012-2017)
    2.3 EMEA Penicillin/Streptomycin (Volume) by Application
    2.4 EMEA Penicillin/Streptomycin (Volume and Value) by Region
        2.4.1 EMEA Penicillin/Streptomycin Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Penicillin/Streptomycin Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Penicillin/Streptomycin Sales Price by Region (2012-2017)

3 Europe Penicillin/Streptomycin (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Penicillin/Streptomycin Sales and Value (2012-2017)
        3.1.1 Europe Penicillin/Streptomycin Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Penicillin/Streptomycin Revenue and Growth Rate (2012-2017)
    3.2 Europe Penicillin/Streptomycin Sales and Market Share by Type
    3.3 Europe Penicillin/Streptomycin Sales and Market Share by Application
    3.4 Europe Penicillin/Streptomycin Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Penicillin/Streptomycin Sales Volume by Countries (2012-2017)
        3.4.2 Europe Penicillin/Streptomycin Revenue by Countries (2012-2017)
        3.4.3 Germany Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        3.4.4 France Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        3.4.5 UK Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        3.4.6 Russia Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        3.4.7 Italy Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Penicillin/Streptomycin Sales and Growth Rate (2012-2017)

4 Middle East Penicillin/Streptomycin (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Penicillin/Streptomycin Sales and Value (2012-2017)
        4.1.1 Middle East Penicillin/Streptomycin Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Penicillin/Streptomycin Revenue and Growth Rate (2012-2017)
    4.2 Middle East Penicillin/Streptomycin Sales and Market Share by Type
    4.3 Middle East Penicillin/Streptomycin Sales and Market Share by Application
    4.4 Middle East Penicillin/Streptomycin Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Penicillin/Streptomycin Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Penicillin/Streptomycin Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        4.4.4 Israel Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        4.4.5 UAE Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        4.4.6 Iran Penicillin/Streptomycin Sales and Growth Rate (2012-2017)

5 Africa Penicillin/Streptomycin (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Penicillin/Streptomycin Sales and Value (2012-2017)
        5.1.1 Africa Penicillin/Streptomycin Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Penicillin/Streptomycin Revenue and Growth Rate (2012-2017)
    5.2 Africa Penicillin/Streptomycin Sales and Market Share by Type
    5.3 Africa Penicillin/Streptomycin Sales and Market Share by Application
    5.4 Africa Penicillin/Streptomycin Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Penicillin/Streptomycin Sales Volume by Countries (2012-2017)
        5.4.2 Africa Penicillin/Streptomycin Revenue by Countries (2012-2017)
        5.4.3 South Africa Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Penicillin/Streptomycin Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Penicillin/Streptomycin Sales and Growth Rate (2012-2017)

6 EMEA Penicillin/Streptomycin Manufacturers/Players Profiles and Sales Data
    6.1 Johnson & Johnson
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Johnson & Johnson Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Bayer HealthCare
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer HealthCare Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abbot Laboratories
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abbot Laboratories Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Roche Pharmaceuticals
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Roche Pharmaceuticals Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Sanofi Aventis
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sanofi Aventis Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Takeda Pharmaceutical Company
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Takeda Pharmaceutical Company Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Toyama Chemical
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Toyama Chemical Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Merck & Co.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Merck & Co. Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 MiddleBrook Pharmaceuticals
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Penicillin/Streptomycin Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 MiddleBrook Pharmaceuticals Penicillin/Streptomycin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Novartis
    6.12 Biogen IDEC
    6.13 Bristol Myers Squibb
    6.14 Celgine Corporation
    6.15 Eli Lilly and Co
    6.16 Gilead Sciences
    6.17 GlaxoSmithKline
    6.18 Amgen
    6.19 Astellas Pharma
    6.20 Astra Zeneca

7 Penicillin/Streptomycin Manufacturing Cost Analysis
    7.1 Penicillin/Streptomycin Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Penicillin/Streptomycin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Penicillin/Streptomycin Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Penicillin/Streptomycin Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Penicillin/Streptomycin Market Forecast (2017-2022)
    11.1 EMEA Penicillin/Streptomycin Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Penicillin/Streptomycin Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Penicillin/Streptomycin Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Penicillin/Streptomycin Price and Trend Forecast (2017-2022)
    11.2 EMEA Penicillin/Streptomycin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Penicillin/Streptomycin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Penicillin/Streptomycin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Penicillin/Streptomycin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Penicillin/Streptomycin Sales Forecast by Type (2017-2022)
    11.7 EMEA Penicillin/Streptomycin Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer